Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
"Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-nave Subjects With Type 2 Diabetes (SUSTAIN 4)"
Essentially, the entire manufacturing process is inspected from start to finish and the medicine the process creates is tested for safety and effectiveness
Browse nearby locations to learn more about treatment options, telehealth availability, and provider-guided weight management programs
Original research focused primarily on those with diabetes, but a recent study found an increased risk of stomach paralysis for non-diabetic patients who used medications like Ozempic, Wegovy, Rybelsus, and Saxenda for weight loss
